Metformin treatment did not appear to reduce the risk of all-cause or cancer-related mortality in older women with diabetes and breast cancer, a study indicated. The findings were published in Diabetes Care.
Published in Brief:
|Senior Director, Biostatistics||
|Associate - Food and Drug||
Keller and Heckman LLP
|Senior Paralegal - Research & Development, and Medical||